Atypical hyperplasia of breast may be a precancerous lesion of breast cancer. However, it should be noted that simple breast hyperplasia will not cause canceration, but if it is high hyperplasia and atypical hyperplasia of ductal epithelium, it may be precancerous lesions, so we should pay attention to the distinction. Once the latter case is found, it should be regarded as a precancerous lesion of breast cancer and prevented in time.
Japan leads the international level in three-cell immunotherapy.
Cellular immunotherapy in Japan is a general term, including NK cell immunotherapy, T cell immunotherapy and dendritic cell immunotherapy. Because each patient's disease state is different, it is necessary to ask Japanese experts and doctors to evaluate the specific Japanese cellular immunotherapy use plan according to the actual situation of each patient before the cellular immunotherapy treatment!
1, NK cell immunotherapy
NK cells often patrol the blood, and once abnormal cells (such as cancer cells, viruses, bacteria, etc.) appear. ) is found, they will attack immediately, this is the natural enemy of mutant cells. People who lack NK cells are relatively more likely to suffer from serious diseases such as tumors, and improving the activity of NK cells will also reduce the chance of getting sick. Injecting a large number of highly active NK cells will reduce the occurrence of diseases. Restoring the activity and quantity of NK cells to a high level is an excellent way to prevent atypical hyperplasia and canceration of breast!
2.t cell immunotherapy
T cells can find enemies, awaken dormant attack cells and issue attack orders. Among them, specific T lymphocytes have many biological functions, such as directly killing abnormal cells, assisting or inhibiting B cells to produce antibodies, responding to specific antigens and mitogens, and producing cytokines. It is the number one "fighter" to prevent atypical hyperplasia and canceration of breast in the body.
3. Dendritic cell immunotherapy
Dendritic cells are the "commander tower" of immunity, teaching and strengthening the ability to attack cells. Foreign bodies are detected, and the message of "enemy exists" is sent out, which belongs to the cells in the immunized group. Dendritic cells have the ability of immune stimulation, and they are the only immune cells that can activate the initial immune T cells that are not sensitized.
Tamaki Health said that Japanese hospitals have comfortable environment, convenient and fast treatment, and the cost is the lowest among all developed countries. Moreover, from China to Japan, there is no time difference, and the geographical advantages, culture and eating habits are similar to those of China. In the future, more people will join the Japanese medical team and enjoy international medical services. If patients with atypical hyperplasia of mammary glands want to go to Japan for cellular immunotherapy, they can contact Duomu Health for preliminary evaluation and cost estimation at any time.